Podocyte repopulation contributes to regression of glomerular injury induced by ace inhibition

American Journal of Pathology

Volumn 174, Issue 3, 2009, Pages 797-807

  Macconi, Daniela ^a   Sangalli, Fabio ^a   Bonomelli, Maria ^a   Conti, Sara ^a   Condorelli, Lucia ^a   Gagliardini, Elena ^a   Remuzzi, Giuseppe ^a,b   Remuzzi, Andrea ^a,c  

^a MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

^b OSPEDALI RIUNITI   (Italy)

^c UNIVERSITY OF BERGAMO   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE; LISINOPRIL; PROTEIN P27;

AGING; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL COUNT; CELL DENSITY; CELL INFILTRATION; CELL LOSS; CELL PROLIFERATION; CELL VOLUME; CONTROLLED STUDY; DISEASE COURSE; DRUG DOSE INCREASE; ENDOTHELIUM CELL; ENZYME INHIBITION; GLOMERULOPATHY; GLOMERULOSCLEROSIS; GLOMERULUS CAPILLARY; GLOMERULUS EPITHELIUM; HYPERTENSION; IMMUNOHISTOCHEMISTRY; INFLAMMATORY CELL; KIDNEY DISEASE; KIDNEY FUNCTION; KIDNEY STRUCTURE; MALE; MESANGIUM CELL; NONHUMAN; PODOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEINURIA; RAT; WISTAR RAT;

EID: 62549130686     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.2353/ajpath.2009.080227     Document Type: Article

References (44)

1. Ruggenenti P, Schieppati A, Remuzzi G: Progression, remission, regression of chronic renal diseases. Lancet 2001, 357:1601-1608
2. Barnett AH, Bain SC, Bouter P, Karlberg B, Madsbad S, Jervell J, Mustonen J: Angiotensin-receptor blockade versus converting-enzyme inhibition in type 2 diabetes and nephropathy. N Engl J Med 2004, 351:1952-1961
3. Wilmer WA, Hebert LA, Lewis EJ, Rohde RD, Whittier F, Cattran D, Levey AS, Lewis JB, Spitalewitz S, Blumenthal S, Bain RP: Remission of nephrotic syndrome in type 1 diabetes: long-term follow-up of patients in the Captopril Study. Am J Kidney Dis 1999, 34:308-314
4. Ruggenenti P, Perna A, Benini R, Bertani T, Zoccali C, Maggiore Q, Salvadori M, Remuzzi G, Investigators of the GISEN Group Gruppo Italiano Studi Epidemiologici in Nefrologia: In chronic nephropathies prolonged ACE inhibition can induce remission: dynamics of timedependent changes in GFR. J Am Soc Nephrol 1999, 10:997-1006
5. Ruggenenti P, Brenner BM, Remuzzi G: Remission achieved in chronic nephropathy by a multidrug approach targeted at urinary protein excretion. Nephron 2001, 88:254-259
6. Marinides GN, Groggel GC, Cohen AH, Border WA: Enalapril and low protein reverse chronic puromycin aminonucleoside nephropathy. Kidney Int 1990, 37:749-757
7. Boffa JJ, Lu Y, Placier S, Stefanski A, Dussaule JC, Chatziantoniou C: Regression of renal vascular and glomerular fibrosis: role of angiotensin II receptor antagonism and matrix metalloproteinases. J Am Soc Nephrol 2003, 14:1132-1144
8. Adamczak M, Gross ML, Krtil J, Koch A, Tyralla K, Amann K, Ritz E: Reversal of glomerulosclerosis after high-dose enalapril treatment in subtotally nephrectomized rats. J Am Soc Nephrol 2003, 14:2833-2842
9. Fujihara CK, Velho M, Malheiros DM, Zatz R: An extremely high dose of losartan affords superior renoprotection in the remnant model. Kidney Int 2005, 67:1913-1924
10. Ma LJ, Nakamura S, Aldigier JC, Rossini M, Yang H, Liang X, Nakamura I, Marcantoni C, Fogo AB: Regression of glomerulosclerosis with high-dose angiotensin inhibition is linked to decreased plasminogen activator inhibitor-1. J Am Soc Nephrol 2005, 16:966-976
11. Ma LJ, Nakamura S, Whitsitt JS, Marcantoni C, Davidson JM, Fogo AB: Regression of sclerosis in aging by an angiotensin inhibition-induced decrease in PAI-1. Kidney Int 2000, 58:2425-2436
12. Remuzzi A, Fassi A, Bertani T, Perico N, Remuzzi G: ACE inhibition induces regression of proteinuria and halts progression of renal damage in a genetic model of progressive nephropathy. Am J Kidney Dis 1999, 34:626-632
13. Remuzzi A, Gagliardini E, Donadoni C, Fassi A, Sangalli F, Lepre MS, Remuzzi G, Benigni A: Effect of angiotensin II antagonism on the regression of kidney disease in the rat. Kidney Int 2002, 62:885-894
14. Remuzzi A, Gagliardini E, Sangalli F, Bonomelli M, Piccinelli M, Benigni A, Remuzzi G: ACE inhibition reduces glomerulosclerosis and regenerates glomerular tissue in a model of progressive renal disease. Kidney Int 2006, 69:1124-1130
15. Wharram BL, Goyal M, Wiggins JE, Sanden SK, Hussain S, Filipiak WE, Saunders TL, Dysko RC, Kohno K, Holzman LB, Wiggins RC: Podocyte depletion causes glomerulosclerosis: diphtheria toxin-induced podocyte depletion in rats expressing human diphtheria toxin receptor transgene. J Am Soc Nephrol 2005, 16:2941-2952
16. Macconi D, Bonomelli M, Benigni A, Plati T, Sangalli F, Longaretti L, Conti S, Kawachi H, Hill P, Remuzzi G, Remuzzi A: Pathophysiologic implications of reduced podocyte number in a rat model of progressive glomerular injury. Am J Pathol 2006, 168:42-54
17. Remuzzi A, Puntorieri S, Alfano M, Macconi D, Abbate M, Bertani T, Remuzzi G: Pathophysiologic implications of proteinuria in a rat model of progressive glomerular injury. Lab Invest 1992, 67:572-579
18. Mundlos S, Pelletier J, Darveau A, Bachmann M, Winterpacht A, Zabel B: Nuclear localization of the protein encoded by the Wilms' tumor gene WT1 in embryonic and adult tissues. Development 1993, 119:1329-1341
19. Duijvestijn AM, van Goor H, Klatter F, Majoor GD, van Bussel E, van Breda Vriesman PJ: Antibodies defining rat endothelial cells: rECA-1, a pan-endothelial cell-specific monoclonal antibody. Lab Invest 1992, 66:459-466
20. Ricono JM, Xu YC, Arar M, Jin DC, Barnes JL, Abboud HE: Morphological insights into the origin of glomerular endothelial and mesangial cells and their precursors. J Histochem Cytochem 2003, 51:141-150
21. Scholzen T, Gerdes J: The Ki-67 protein: from the known and the unknown. J Cell Physiol 2000, 182:311-322
22. Shirato I, Asanuma K, Takeda Y, Hayashi K, Tomino Y: Protein gene product 9.5 is selectively localized in parietal epithelial cells of Bowman's capsule in the rat kidney. J Am Soc Nephrol 2000, 11:2381-2386
23. Weibel ER: Stereological methods. Practical methods for biological morphometry. London, Academic Press Inc., 1979, 40-116
24. Teta M, Rankin MM, Long SY, Stein GM, Kushner JA: Growth and regeneration of adult beta cells does not involve specialized progenitors. Dev Cell 2007, 12:817-826
25. Shankland SJ, Wolf G: Cell cycle regulatory proteins in renal disease: role in hypertrophy, proliferation, and apoptosis. Am J Physiol Renal Physiol 2000, 278:F515-F529
26. Marshall CB, Shankland SJ: Cell cycle regulatory proteins in podocyte health and disease. Nephron Exp Nephrol 2007, 106:e51-59
27. Gibson IW, Downie I, Downie TT, Han SW, More IA, Lindop GB: The parietal podocyte: a study of the vascular pole of the human glomerulus. Kidney Int 1992, 41:211-214
28. Bariety J, Mandet C, Hill GS, Bruneval P: Parietal podocytes in normal human glomeruli. J Am Soc Nephrol 2006, 17:2770-2780
29. Fassi A, Sangalli F, Maffi R, Colombi F, Mohamed EI, Brenner BM, Remuzzi G, Remuzzi A: Progressive glomerular injury in the MWF rat is predicted by inborn nephron deficit. J Am Soc Nephrol 1998, 9:1399-1406
30. Wiggins JE, Goyal M, Sanden SK, Wharram BL, Shedden KA, Misek DE, Kuick RD, Wiggins RC: Podocyte hypertrophy, "adaptation," and "decompensation" associated with glomerular enlargement and glomerulosclerosis in the aging rat: prevention by calorie restriction. J Am Soc Nephrol 2005, 16:2953-2966
31. Petermann AT, Pippin J, Durvasula R, Pichler R, Hiromura K, Monkawa T, Couser WG, Shankland SJ: Mechanical stretch induces podocyte hypertrophy in vitro. Kidney Int 2005, 67:157-166
32. Gross ML, El-Shakmak A, Szabo A, Koch A, Kuhlmann A, Munter K, Ritz E, Amann K: ACE-inhibitors but not endothelin receptor blockers prevent podocyte loss in early diabetic nephropathy. Diabetologia 2003, 46:856-868
33. Kriz W: Progressive renal failure-inability of podocytes to replicate and the consequences for development of glomerulosclerosis. Nephrol Dial Transplant 1996, 11:1738-1742
34. Xu ZG, Yoo TH, Ryu DR, Cheon Park H, Ha SK, Han DS, Adler SG, Natarajan R, Kang SW: Angiotensin II receptor blocker inhibits p27Kip1 expression in glucose-stimulated podocytes and in diabetic glomeruli. Kidney Int 2005, 67:944-952
35. Griffin SV, Petermann AT, Durvasula RV, Shankland SJ: Podocyte proliferation and differentiation in glomerular disease: role of cell-cycle regulatory proteins, Nephrol Dial Transplant 2003, 18 Suppl 6:vi8-13
36. Tsui CC, Shankland SJ, Pierchala BA: Glial cell line-derived neurotrophic factor and its receptor ret is a novel ligand-receptor complex critical for survival response during podocyte injury. J Am Soc Nephrol 2006, 17:1543-1552
37. Shi H, Patschan D, Dietz GP, Bahr M, Plotkin M, Goligorsky MS: Glial cell line-derived neurotrophic growth factor increases motility and survival of cultured mesenchymal stem cells and ameliorates acute kidney injury. Am J Physiol Renal Physiol 2008, 294:F229-F235
38. Sagrinati C, Netti GS, Mazzinghi B, Lazzeri E, Liotta F, Frosali F, Ronconi E, Meini C, Gacci M, Squecco R, Carini M, Gesualdo L, Francini F, Maggi E, Annunziato F, Lasagni L, Serio M, Romagnani S, Romagnani P: Isolation and characterization of multipotent progenitor cells from the Bowman's capsule of adult human kidneys. J Am Soc Nephrol 2006, 17:2443-2456
39. Gibson IW, Downie TT, More IA, Lindop GB: Tuft-to-capsule adhesions and their precursors: differences between the vascular and tubular poles of the human glomerulus. J Pathol 1998, 184:430-435
40. Becker JU, Hoerning A, Schmid KW, Hoyer PF: Immigrating progenitor cells contribute to human podocyte turnover. Kidney Int 2007, 72:1468-1473
41. Poulsom R, Forbes SJ, Hodivala-Dilke K, Ryan E, Wyles S, Navaratnarasah S, Jeffery R, Hunt T, Alison M, Cook T, Pusey C, Wright NA: Bone marrow contributes to renal parenchymal turnover and regeneration. J Pathol 2001, 195:229-235
42. Prodromidi EI, Poulsom R, Jeffery R, Roufosse CA, Pollard PJ, Pusey CD, Cook HT: Bone marrow-derived cells contribute to podocyte regeneration and amelioration of renal disease in a mouse model of Alport syndrome. Stem Cells 2006, 24:2448-2455
43. Liang XB, Ma LJ, Naito T, Wang Y, Madaio M, Zent R, Pozzi A, Fogo AB: Angiotensin type 1 receptor blocker restores podocyte potential to promote glomerular endothelial cell growth. J Am Soc Nephrol 2006, 17:1886-1895
44. Kretzler M: Role of podocytes in focal sclerosis: defining the point of no return. J Am Soc Nephrol 2005, 16:2830-2832